Tert-butyl 4-[2-(7-fluoro-4-methoxy-2-methylindazol-5-yl)thieno[2,3-d][1,3]thiazol-5-yl]piperidine-1-carboxylate
C24H27FN4O3S2 — CID 162433062
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[2-(7-fluoro-4-methoxy-2-methylindazol-5-yl)thieno[2,3-d][1,3]thiazol-5-yl]piperidine-1-carboxylate
Tert-butyl 4-[2-(7-fluoro-4-methoxy-2-methylindazol-5-yl)thieno[2,3-d][1,3]thiazol-5-yl]piperidine-1-carboxylate (PubChem CID 162433062) has the molecular formula C24H27FN4O3S2 and a molecular weight of 502.64 g/mol. Its IUPAC name is tert-butyl 4-[2-(7-fluoro-4-methoxy-2-methylindazol-5-yl)thieno[2,3-d][1,3]thiazol-5-yl]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[2-(7-fluoro-4-methoxy-2-methylindazol-5-yl)thieno[2,3-d][1,3]thiazol-5-yl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 162433062 |
| Molecular Formula | C24H27FN4O3S2 |
| Molecular Weight | 502.64 g/mol |
| Exact Mass | 502.15 |
| IUPAC Name | tert-butyl 4-[2-(7-fluoro-4-methoxy-2-methylindazol-5-yl)thieno[2,3-d][1,3]thiazol-5-yl]piperidine-1-carboxylate |
| SMILES | COc1c(-c2nc3sc(C4CCN(C(=O)OC(C)(C)C)CC4)cc3s2)cc(F)c2nn(C)cc12 |
| InChI | InChI=1S/C24H27FN4O3S2/c1-24(2,3)32-23(30)29-8-6-13(7-9-29)17-11-18-22(33-17)26-21(34-18)14-10-16(25)19-15(20(14)31-5)12-28(4)27-19/h10-13H,6-9H2,1-5H3 |
| InChIKey | HRPXVTKPZUKMIG-UHFFFAOYSA-N |
| XLogP | 6.17 |
| TPSA | 69.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.64 |
| LogP ≤ 5 | 6.17 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162433062 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.